
The latest thought leadership from our expert teams

Creating robust bioprocessing scale-down models
Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.
- Bioinnovation

Exploring the potential for non-contact monitoring for sepsis, the quick and costly killer
Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings.
- AI & Analytics
- Connectivity & IoT
- Digital health
- Sensing
- Signal processing

The future of patient monitoring
Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...
- AI & Analytics
- Connectivity & IoT
- Digital health
- Digital security
- Digital service innovation
- Human factors
- Product realisation
- Sensing
- User Experience (UX)

Global partnership with MedTech Innovator
Cambridge Consultants expands its innovation partnership with MedTech Innovator to help accelerate medtech start ups
- Digital health
- Innovation management
- Strategic advice

Novel semi-supervised learning to accelerate R&D of AI-powered cancer pathology
What is semi-supervised machine learning? And what could it mean for the research and development of a new generation of AI-powered digital medical systems? Andrew Goulter reports on state-of-the art deep learning research at CC that promises huge savings in the time and expense of development, while augmenting the skills of pathologists…
- AI & Analytics
- Digital health

From bench to scale: our workshop insights for tough tech start ups
It soon becomes crunch time for an entrepreneurial start up with a ground-breaking idea in tough tech innovation. While exploring some of the details of CC’s workshop approach, Roger Mainwaring-Burton reveal the secrets of taking a product, service or company from benchtop to scale to success in the market…
- Innovation management
- Product realisation
- Project management
- Strategic advice

Trusting autonomy and ensuring quantum resilience for government as security threats emerge
Potential quantum attacks on government agencies and the military are part and parcel of the changing security landscape. In turn, government organizations are exploring the use of quantum for defense security, as well as the efficiencies of future states that these technologies will enable for mission-critical operations.
- Innovation management
- Product realisation
- Project management
- Strategic advice

Bioprocessing meets machine learning: the conversation that is driving a cell therapy breakthrough
A meeting of minds - AI meets biology. This is the conversation that is bridging the gap between bioprocessing and machine learning.
- AI & Analytics
- Bioinnovation
- Cell and gene therapy
- Synthetic biology

Quantum cloud computing plus digital service innovation will equal commercial advantage
What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered by quantum technologies…
- Cloud/scalable systems
- Digital service innovation
- Innovation management
- Strategic advice

Genomics, panomics and long read sequencing – a path to better patient care?
Fresh from the Festival of Genomics and Biodata, our Head of Life Sciences Symon Cotton reflected on the future of the genomics ecosystem. Here he discusses how genomics – plus the emergence of panomics and long read sequencing – could inform clinical practice and patient care…
- AI & Analytics
- Cell and gene therapy
- Optics
- Sensing

My career journey as a woman in STEM
Being a woman in STEM is something I am proud of. Subjects such as science, technology, engineering, and mathematics (STEM) have always been a huge passion of mine – and so working at a company like Cambridge Consultants that has been at the forefront of innovative development for over 60 years is perfect for me.
- Bioinnovation
- Cell and gene therapy

Quantum sensing technology for the life sciences – exploring the potential
Swiss company Qnami, a leader in quantum sensing technology, tasked us with identifying potential applications in the biomedical area where NV magnetometry could provide clinical value and open new commercial avenues.
- AI & Analytics
- Innovation management
- Physical sciences
- Strategic advice